FDA Adverse Event Injury Summary report: N

ATUNE REV RP TIB BASE SZ 7 CEM

MDR report key: 17773569 · Received September 19, 2023

Report

Report Number
1818910-2023-19060
Event Type
Injury
Date Received
September 19, 2023
Date of Event
January 1, 2023
Report Date
September 19, 2023
Manufacturer
DEPUY IRELAND - 9616671
Product Code
NJL
UDI-DI
10603295042914
PMA / PMN Number
P830055
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

PRODUCT COMPLAINT (B)(4). INVESTIGATION SUMMARY: NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. PRODUCT DESCRIPTION: ATUNE REV RP TIB BASE SZ 7 CEM. PRODUCT CODE: 150660007. LOT NUMBER: 9033554 1) QUANTITY MANUFACTURED: (B)(4). 2) DATE OF MANUFACTURE: 19-FEB-2019. 3) ANY ANOMALIES OR DEVIATIONS IDENTIFIED IN DHR: NO NON-CONFORMANCES / MANUFACTURING IRREGULARITIES RELATED TO THE MALFUNCTION WERE IDENTIFIED. 4) EXPIRY DATE: 31-JAN-2029. 5) IFU REFERENCE: 090200876. AS PART OF OUR COMPANY QUALITY SYSTEM PROCESS, ALL DEVICES ARE MANUFACTURED, INSPECTED, AND DISTRIBUTED TO APPROVED SPECIFICATIONS. ADDITIONAL COMPLAINT INFORMATION MONITORING FOR POTENTIAL SAFETY SIGNALS WILL BE CONDUCTED THROUGH COMPLAINT TRENDING AS PART OF THE POST-MARKET SURVEILLANCE. IF ADDITIONAL INFORMATION IS MADE AVAILABLE, THE INVESTIGATION WILL BE UPDATED AS APPLICABLE. DEVICE HISTORY LOT: PRODUCT DESCRIPTION: ATUNE REV RP TIB BASE SZ 7 CEM. PRODUCT CODE: 150660007. LOT NUMBER: 9033554. 1) QUANTITY MANUFACTURED: (B)(4). 2) DATE OF MANUFACTURE: 19-FEB-2019. 3) ANY ANOMALIES OR DEVIATIONS IDENTIFIED IN DHR: NO NON-CONFORMANCES / MANUFACTURING IRREGULARITIES RELATED TO THE MALFUNCTION WERE IDENTIFIED. 4) EXPIRY DATE: 31-JAN-2029. 5) IFU REFERENCE: 090200876.

Additional Manufacturer Narrative · 0

PRODUCT COMPLAINT # (B)(4). D4-EXPIRATION DATE OF THE DEVICE WAS NOT PROVIDED. THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803 (AND/OR PART 4, AS APPLICABLE). THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY DEPUY SYNTHES, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, DEPUY SYNTHES, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 0

CLINICAL ADVERSE EVENT RECEIVED FOR SLIGHT GAIT INSTABILITY LEFT KNEE. EVENT IS NOT SERIOUS AND IS CONSIDERED MILD. EVENT IS POSSIBLY RELATED TO DEVICE. EVENT IS NOT RELATED TO PROCEDURE. DATE OF IMPLANT: (B)(6) 2019 DATE OF EVENT: UNKNOWN IN 2023 (LEFT KNEE). TREATMENT: RECOMMENDATION FOR KNEE CONTROL IN THE ORTHOPEDIC DEPARTMENT. DEPUY PRODUCTS USED (NO REVISION COMPLETED)

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1997972 ATUNE REV RP TIB BASE SZ 7 CEM KNEE TIBIAL TRAY NJL DEPUY IRELAND - 9616671 9033554 10603295042914

Patients

Seq Age Sex Outcome Treatment
1 67 YR Male Required Intervention ATTUNE MEDIAL DOME PAT 41MM.| ATTUNE PS FEM LT SZ 8 CEM.| ATTUNE PS RP INSRT SZ8 6MM.| ATUN TIB SLV M/L 45MM HALF POR.| ATUNE PRESSFIT STR STEM14X60MM.| COMPETITOR PRODUCT (BIOMET CEMENT).